Table 3 Extent of exposure (maximum 24 ampoules = 100%), percentage of subjects with local reactions and tolerability.
Iscucin®Populi | Viscum Mali e planta tota | Placebo | |||||||
|---|---|---|---|---|---|---|---|---|---|
(n = 30) | (n = 21) | (n = 20) | |||||||
0.0125% | 0.25% | 5% | 1:1000 | 1:100 | 1:50 | ||||
strength | strength | strength | D3 | D2 | 2% | ||||
F | G | H | |||||||
Week | Week | Week | Week | Week | Week | Week | Week | Week | |
1-4 | 5-8 | 9-12 | 1-4 | 5-8 | 9-12 | 1-4 | 5-8 | 9-12 | |
Overall injected ampoules (%) | 100.0 | 81.7 | 64.0 | 100.0 | 100.0 | 99.1 | 99.7 | 99.8 | 99.9 |
Local reactions % | 17 | 93 | 93 | 0 | 19 | 19 | 0 | 0 | 0 |
Tolerability (%) | ** | ** | * | ||||||
Bad | 0 | 28 | 21 | 0 | 0 | 0 | 0 | 0 | 0 |
Moderate | 3 | 38 | 45 | 0 | 0 | 0 | 5 | 0 | 0 |
Good | 21 | 34 | 34 | 5 | 14 | 29 | 0 | 0 | 0 |
Excellent | 76 | 0 | 0 | 95 | 86 | 71 | 95 | 100 | 100 |